Agranulocytosis during dapsone administration.
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000188:drug therapy; D006801:Humans; D008297:Male
D003622:Dapsone